Endoscopic Healing of Crohn ' s Disease Could Differ by Biologic Endoscopic Healing of Crohn ' s Disease Could Differ by Biologic
Infliximab biosimilar and adalimumab resulted in better endoscopic healing rates than either vedolizumab or ustekinumab in a post hoc pooled analysis.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news
More News: Crohn's Disease | Gastroenterology | Humira | Inflammatory Bowel Disease | Remicade | Stelara